These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9033377)

  • 21. Method of tumor detection influences disease-free survival of women with breast carcinoma.
    Senie RT; Lesser M; Kinne DW; Rosen PP
    Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of ductal carcinoma in situ.
    Hetelekidis S; Schnitt SJ; Morrow M; Harris JR
    CA Cancer J Clin; 1995; 45(4):244-53. PubMed ID: 7600280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premalignant and malignant disease of the breast: the roles of the pathologist.
    Page DL; Jensen RA; Simpson JF
    Mod Pathol; 1998 Feb; 11(2):120-8. PubMed ID: 9504682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Christchurch Breast Cancer Patient Register: the first year.
    Davey V; Robinson B; Dijkstra B; Harris G
    N Z Med J; 2012 Aug; 125(1360):37-47. PubMed ID: 22932653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rare presentation of breast cancer.
    Rappaport A; Van Steen A; Van Ongeval C
    JBR-BTR; 2011; 94(2):75-7. PubMed ID: 21699039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.
    Hillner BE; Desch CE; Carlson RW; Smith TJ; Esserman L; Bear HD
    J Clin Oncol; 1996 Jan; 14(1):70-7. PubMed ID: 8558224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
    Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In situ ductal carcinoma of the breast].
    Peña-Estévez VL; Aguilar U; Torrescano Granillo A
    Ginecol Obstet Mex; 1999 Feb; 67():43-9. PubMed ID: 10327763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.
    Meijnen P; Peterse JL; Oldenburg HS; Woerdeman LA; Rutgers EJ
    Eur J Surg Oncol; 2005 Oct; 31(8):833-9. PubMed ID: 15923104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; Van Dijck JA; Wobbes T
    Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild.
    Page DL; Jensen RA
    JAMA; 1996 Mar; 275(12):948-9. PubMed ID: 8598624
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of magnetic resonance imaging for detecting clinically and mammographically occult ductal carcinoma in situ.
    Lo G; Cheung P
    Hong Kong Med J; 2008 Jun; 14(3):229-32. PubMed ID: 18525094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
    Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
    Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
    Bauer TL; Pandelidis SM; Rhoads JE
    J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.